Valuation: ALK-Abelló A/S

Market Cap 53.38B 8B 7.14B 6.6B 5.98B 11.19B 759B 11.37B 79.4B 31.43B 398B 30.01B 29.38B 1,254B P/E 2026 *
35.7x
P/E 2027 * 32.6x
Enterprise Value 51.75B 7.75B 6.92B 6.4B 5.8B 10.84B 736B 11.02B 76.96B 30.47B 386B 29.1B 28.48B 1,216B EV / Sales 2026 *
7.05x
EV / Sales 2027 * 6.18x
Free-Float
59.16%
Yield 2026 *
0.73%
Yield 2027 * 0.78%
1 day+1.08%
1 week+6.77%
Current month+22.38%
1 month+22.63%
3 months+6.30%
6 months+7.82%
Current year+6.21%
1 week 227.6
Extreme 227.6
243.8
1 month 194.1
Extreme 194.1
243.8
Current year 191.8
Extreme 191.8
271.4
1 year 191.8
Extreme 191.8
271.4
3 years 74.3
Extreme 74.3
271.4
5 years 69.9
Extreme 69.9
271.4
10 years 32.3
Extreme 32.3
271.4
Manager TitleAgeSince
Chief Executive Officer 49 2023-12-31
Director of Finance/CFO 54 2023-05-31
Chief Tech/Sci/R&D Officer 52 2026-08-31
Director TitleAgeSince
Director/Board Member 57 2010-12-31
Director/Board Member 67 2013-12-31
Director/Board Member 67 2015-03-11
Date Insider Type Main position Quantity % Market Cap. Importance
3/4/25 Free

Executive/Senior Manager

6,902 0.0034%
3/4/25 Free

Executive/Senior Manager

29,104 0.0144%
2/21/25 Buy

Chief Executive Officer

1,606 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%+6.77%+12.41%+214.10% 8B
-2.96%+0.83%+54.38%+119.80% 1,165B
-1.43%+3.15%+36.96%+74.13% 645B
+0.11%-0.05%+24.99%+97.12% 504B
-0.31%+3.09%+43.92%+64.55% 380B
-1.53%-0.51%+66.55%+40.49% 363B
-0.68%+2.65%+22.46%+51.48% 297B
-1.20%+3.04%+2.62%+26.97% 269B
-1.64%+1.85%+50.40%+61.32% 237B
-0.26%+0.42%+29.91%+102.23% 195B
Average -0.92%+2.63%+34.46%+85.22% 406.35B
Weighted average by Cap. -1.51%+3.17%+40.83%+82.26%

Financials

2026 *2027 *
Net sales 7.34B 1.1B 982M 907M 822M 1.54B 104B 1.56B 10.91B 4.32B 54.67B 4.13B 4.04B 172B 8.23B 1.23B 1.1B 1.02B 921M 1.72B 117B 1.75B 12.23B 4.84B 61.29B 4.62B 4.53B 193B
Net income 1.5B 224M 200M 185M 168M 314M 21.28B 319M 2.23B 881M 11.15B 841M 823M 35.15B 1.64B 246M 219M 203M 184M 344M 23.32B 349M 2.44B 966M 12.22B 922M 902M 38.53B
Net Debt -1.63B -245M -219M -202M -183M -343M -23.25B -348M -2.43B -963M -12.18B -919M -900M -38.4B -2.56B -384M -343M -317M -287M -537M -36.48B -546M -3.81B -1.51B -19.11B -1.44B -1.41B -60.25B
Projected Income Statement - Annual - ALK-Abelló A/S
Logo ALK-Abelló A/S
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.
Employees
2,773
Date Price Change Volume
26-10-23 DKK 242.80 +0.91% 156,341
26-10-22 DKK 240.60 -0.82% 126,480
26-10-21 DKK 242.60 +2.02% 257,796
26-10-20 DKK 237.80 +0.34% 232,917
26-10-19 DKK 237.00 +4.22% 400,301
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - ALK-Abelló A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
240.60DKK
Average target price
287.50DKK
Spread / Average Target
+19.49%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ALK-Abelló A/S
  1. Stock Market
  2. Stocks
  3. ALK B Stock